AbbVie's Rinvoq gets approval in Canada for expanded use in axial spondyloarthritis (ABBV)

Health Canada approved AbbVie’s (ABBV) Rinvoq to treat adults with active non-radiographic axial spondyloarthritis (nr-axSpA). Read more here